首页> 外国专利> CONSTRUCTION OF CELLS EXPRESSING GENES OF DISEASES RELATED TO MITOCHONDRIAL PROTEIN UQCRB AND CONSTRUCTION OF EVALUATION METHOD ADJUSTING FUNCTIONS OF UQCRB USING SAME

CONSTRUCTION OF CELLS EXPRESSING GENES OF DISEASES RELATED TO MITOCHONDRIAL PROTEIN UQCRB AND CONSTRUCTION OF EVALUATION METHOD ADJUSTING FUNCTIONS OF UQCRB USING SAME

机译:线粒体蛋白UQCRB相关疾病基因表达细胞的构建及使用相同方法调节UQCRB功能的评价方法的构建

摘要

The present invention relates to mitochondrial Ubiquinol-cytochrome c reductase binding protein (UQCRB) mutant cell strain expressing UQCRB mutant proteins. In the present invention, provided are an anticancer activity evaluation method, a vascularization inhibitory activity evaluation method, and a method for screening substances inhibiting activity of UQCRB as novel research methods of UQCRB activity evaluation using a novel mitochondrial UQCRB mutant cell strain. Particularly, the cell strain of the present invention is a novel cell strain having activity to induce cell proliferation and vascularization, and provides a method for screening substances inhibiting vascularization or anticancer substances through an inhibitory mechanism on UQCRB activity, thereby being useful to apply for developing medicine for vascularization, mitochondria-mediated diseases, and various cancers.;COPYRIGHT KIPO 2016
机译:本发明涉及表达UQCRB突变蛋白的线粒体泛醇-细胞色素C还原酶结合蛋白(UQCRB)突变细胞株。在本发明中,作为使用新的线粒体UQCRB突变细胞株的UQCRB活性评估的新研究方法,提供了抗癌活性评估方法,血管生成抑制活性评估方法和筛选抑制UQCRB活性的物质的方法。特别地,本发明的细胞株是具有诱导细胞增殖和血管生成的活性的新型细胞株,并且提供了通过对UQCRB活性的抑制机制来筛选抑制血管生成的物质或抗癌物质的方法,从而可用于开发用于血管生成,线粒体介导的疾病和各种癌症的药物。; COPYRIGHT KIPO 2016

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号